» Articles » PMID: 36340770

Fronto-medial Electrode Placement for Electroconvulsive Treatment of Depression

Overview
Journal Front Neurosci
Date 2022 Nov 7
PMID 36340770
Authors
Affiliations
Soon will be listed here.
Abstract

Electroconvulsive therapy (ECT) is the most effective treatment for severe treatment-resistant depression but concern about cognitive side-effects, particularly memory loss, limits its use. Recent observational studies on large groups of patients who have received ECT report that cognitive side-effects were associated with electric field (EF) induced increases in hippocampal volume, whereas therapeutic efficacy was associated with EF induced increases in sagittal brain structures. The aim in the present study was to determine whether a novel fronto-medial (FM) ECT electrode placement would minimize electric fields in bilateral hippocampi (HIP) whilst maximizing electric fields in dorsal sagittal cortical regions. An anatomically detailed computational head model was used with finite element analysis, to calculate ECT-induced electric fields in specific brain regions identified by translational neuroimaging studies of treatment-resistant depressive illness, for a range of electrode placements. As hypothesized, compared to traditional bitemporal (BT) electrode placement, a specific FM electrode placement reduced bilateral hippocampal electric fields two-to-three-fold, whilst the electric fields in the dorsal anterior cingulate (dAC) were increased by approximately the same amount. We highlight the clinical relevance of this specific FM electrode placement for ECT, which may significantly reduce cognitive and non-cognitive side-effects and suggest a clinical trial is indicated.

References
1.
Whiteford H, Degenhardt L, Rehm J, Baxter A, Ferrari A, Erskine H . Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382(9904):1575-86. DOI: 10.1016/S0140-6736(13)61611-6. View

2.
Anderson I, McAllister-Williams R, Downey D, Elliott R, Loo C . Cognitive function after electroconvulsive therapy for depression: relationship to clinical response. Psychol Med. 2020; 51(10):1647-1656. PMC: 8327625. DOI: 10.1017/S0033291720000379. View

3.
Haghighi M, Sedighinejad A, Nabi B, Emiralavi C, Biazar G, Mirmozaffari K . The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT). Anesth Pain Med. 2016; 6(3):e33724. PMC: 5055710. DOI: 10.5812/aapm.33724. View

4.
Rupprechter S, Romaniuk L, Series P, Hirose Y, Hawkins E, Sandu A . Blunted medial prefrontal cortico-limbic reward-related effective connectivity and depression. Brain. 2020; 143(6):1946-1956. PMC: 7296844. DOI: 10.1093/brain/awaa106. View

5.
Mayberg H, Lozano A, Voon V, McNeely H, Seminowicz D, Hamani C . Deep brain stimulation for treatment-resistant depression. Neuron. 2005; 45(5):651-60. DOI: 10.1016/j.neuron.2005.02.014. View